Literature DB >> 15652140

GENE impedance: a natural process for control of gene expression and the origin of RNA interference.

M Bahman Bahramian1, Helmut Zarbl.   

Abstract

Gene expression is controlled by coordinated transcriptional and post-transcriptional mechanisms. Normally, expression of a gene switches on and off in response to specific physiological signals that are triggered by cellular demand for the gene products at a given time. Based on our previous studies and the scientific literature, we hypothesize that when a gene promoter switches to transcriptional repression mode, transcription of the gene ceases, and a small amount of double-stranded RNA (dsRNA) is synthesized by the RNA polymerase switching to the opposite DNA strand at the termination region of the gene. These dsRNA structures, which result from normal transcriptional repression, can then be processed into short interfering RNAs (siRNAs) within the nucleus. These molecules subsequently direct specific cleavage of the cognate mRNAs and interfere with their translation through sequence complementarily. We further hypothesize that cellular defense mechanisms invoked by invading genetic elements could be rooted in this fundamental regulatory pathway that we call "GENE impedance", or simply, GENEi. Here, we present a working model that illustrates how transcription-termination and transcription-arrest can contribute to the regulation of gene expression via GENEi. In our model RNAi is only one component of GENEi, which is a more generalized mechanism of gene regulation.

Mesh:

Substances:

Year:  2004        PMID: 15652140     DOI: 10.1016/j.jtbi.2004.10.007

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  2 in total

1.  Human CD14 expressed in seeds of transgenic tobacco displays similar proteolytic resistance and bioactivity with its mammalian-produced counterpart.

Authors:  David R Blais; Illimar Altosaar
Journal:  Transgenic Res       Date:  2006-04       Impact factor: 2.788

Review 2.  New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles.

Authors:  M A Zaimy; N Saffarzadeh; A Mohammadi; H Pourghadamyari; P Izadi; A Sarli; L K Moghaddam; S R Paschepari; H Azizi; S Torkamandi; J Tavakkoly-Bazzaz
Journal:  Cancer Gene Ther       Date:  2017-06-02       Impact factor: 5.987

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.